✨ Free AI Report
ChemoMetec A/S: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research ChemoMetec A/S
Company Research

ChemoMetec A/S: Business Overview, Financials & Competitive Analysis

ChemoMetec A/S scores 7/10 on the AskCyborg Cyborg Score (Strong). Specialized automation supplier capturing consolidation opportunity in precision cell analysis with recurring revenue model and pharma/biotech industry tailwinds. ChemoMetec demonstrates solid competitive positioning in a niche but growing market for precision biotech instrumentation. The company benefits from high barriers to entry, recurring consumables revenue, and strategic M&A activity. However, as.

What is ChemoMetec A/S's industry? ChemoMetec A/S (chemometec.com) operates in Life Sciences Instrumentation / Biotech Equipment Manufacturing. AskCyborg classifies ChemoMetec A/S under Life Sciences Instrumentation / Biotech Equipment Manufacturing in its company registry.

ChemoMetec is a Danish biotech instrumentation company specializing in automated cell counting and analysis solutions. Founded in 1997 and publicly listed on Nasdaq OMX Copenhagen, the company manufactures advanced an...

7/ 10Strong

Cyborg Score thesis

Specialized automation supplier capturing consolidation opportunity in precision cell analysis with recurring revenue model and...

Read the full analyst-debate transcript →
Industry Life Sciences Instrumentation / Biotech Equipment Manufacturing
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest ChemoMetec A/S Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for ChemoMetec A/S

AskCyborg analysts argue the bull and bear cases for ChemoMetec A/S across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
ChemoMetec A/S OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

ChemoMetec A/S Overview

Pro stress-test →

ChemoMetec is a Danish biotech instrumentation company specializing in automated cell counting and analysis solutions. Founded in 1997 and publicly listed on Nasdaq OMX Copenhagen, the company manufactures advanced analytical instruments used for quantitative analysis of cells in liquids, serving pharmaceutical, biotechnology, and research sectors globally.

Strategic Profile

Pro stress-test →

ChemoMetec differentiates through proprietary automation technology that eliminates human error and subjectivity in cell counting—a critical requirement in GMP-regulated pharmaceutical production and cell therapy manufacturing. The company employs a recurring revenue model through both instrument sales and consumables, while strategically expanding capabilities through acquisitions like Ovizio Imaging Systems (October 2024) to add holographic microscopy technology for bioprocessing applications.

Competitive Landscape

Pro stress-test →

ChemoMetec operates in the specialized cell analysis instrumentation space competing against larger diversified life sciences equipment manufacturers and niche automation suppliers. Competitors include automated cell counter manufacturers serving pharmaceutical and biotech QC/production, though ChemoMetec's focus on accuracy and regulatory compliance in GMP environments provides differentiation. The market benefits from consolidation trends in cell therapy and bioprocessing automation.

Industry Context

ChemoMetec A/S operates in Life Sciences Instrumentation / Biotech Equipment Manufacturing.

Key facts

Founded: 1997 · Headquarters: Allerød, Denmark · Employees: 51-100

What the analysts stress-tested

The top findings that survived the multi-agent debate for ChemoMetec A/S.

  • NucleoCounter® instrument line provides proprietary advantage in eliminating manual cell counting variability, critical for regulated pharmaceutical manufacturing
  • Ovizio acquisition (October 2024, EUR 2.83M) adds holographic microscopy for continuous bioprocessing monitoring and cell therapy applications—high-margin consumables-focused segment
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • October 2024Completed acquisition of Ovizio Imaging Systems SA for EUR 2.83M, integrating holographic cell counter technology for bioprocessing
  • October 2024Annual General Meeting approved DKK 4 dividend per share and re-elected full board
  • +1 moreTrack every material event for ChemoMetec A/S as it happens. Explore monitoring →
Get alerted when ChemoMetec A/S has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Automated Cell CountersLarge diversified life sciences equipment provider with multiple cell analysis platforms→Flow Cytometry SystemsMajor flow cytometry and cell analysis systems for pharmaceutical and research markets→Manual/Semi-Automated CountingTraditional hemocytometer and microscopy-based methods; ChemoMetec's primary target for displacement→

Compare ChemoMetec A/S with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

ChemoMetec A/S operates in Life Sciences Instrumentation / Biotech Equipment Manufacturing. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences Instrumentation / Biotech Equipment Manufacturing research →
NEW · MCP server

Ask your AI assistant about ChemoMetec A/S

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare ChemoMetec A/S and its top competitor on Cyborg Score”
“What did ChemoMetec A/S do this quarter?”
“Is ChemoMetec A/S a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does ChemoMetec A/S do?+
ChemoMetec is a Danish biotech instrumentation company specializing in automated cell counting and analysis solutions. Founded in 1997 and publicly listed on Nasdaq OMX Copenhagen, the company manufactures advanced an...
What is ChemoMetec A/S's Cyborg Score?+
ChemoMetec A/S has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are ChemoMetec A/S's main competitors?+
Named competitors include Automated Cell Counters, Flow Cytometry Systems, Manual/Semi-Automated Counting. The full competitive landscape is in the AskCyborg report.
How can I get the full ChemoMetec A/S research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the ChemoMetec A/S research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track ChemoMetec A/S over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.